Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine plus aspirin vs aspirin alone for prevention of preeclampsia in high-risk pregnancy
IRCT20221108056440N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in preeclampsia comparing L-arginine + aspirin with aspirin alone (2 arms). Primary endpoint: Incidence of preeclampsia. Started Nov 2022; status: completed.
02
Drugs
arginineaspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20221108056440N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221108056440N1.